Lukas von Stülpnagel

Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial

Konstantinos D. Rizas, Luisa Freyer, Nikolay Sappler et al. · Nature Medicine · 2022 · 104 citations

Electrophysiological Evaluation, Cardiovascular Disease, Remote Patient Monitoring +8

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial

Axel Bauer, Michael Schreinlechner, Nikolay Sappler et al. · The Lancet Respiratory Medicine · 2021 · 101 citations · Full text

Open-label Trial, Hypertension, Cardiovascular Disease +9

Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study

Axel Bauer, Mathias Klemm, Konstantinos D. Rizas et al. · The Lancet · 2019 · 64 citations · Full text

Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial

Axel Bauer, Nikolay Sappler, Lukas von Stülpnagel et al. · The Lancet Digital Health · 2022 · 27 citations · Full text

Risk prediction in post-infarction patients with moderately reduced left ventricular ejection fraction by combined assessment of the sympathetic and vagal cardiac autonomic nervous system

Wolfgang Hamm, Lukas von Stülpnagel, Nikolay Vdovin et al. · International Journal of Cardiology · 2017 · 26 citations

Hypertension, Heart Failure, Cardiogenic Shock +14